As expected - the renal denervation attracted a lot of attention. Beje did a super job hosting both the chats. And Sarah Gleeson accomplished the difficult task of curating those tweets into a coherent narrative!
Background
This week, we will discuss the use of renal autologous cell therapy (REACT) in diabetic kidney disease.
Background
This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.
Background
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
